Literature DB >> 25360314

Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation.

Mariana Milashka1, Annabelle Calomme1, Jean Luc Van Laethem1, Daniel Blero1, Pierre Eisendrath1, Olivier Le Moine1, Jacques Devière1.   

Abstract

OBJECTIVE: The thermal destruction of non-dysplastic Barrett's esophagus (BE) and its replacement by squamous epithelium is an attractive, but unproven strategy to avoid further development of dysplasia or cancer. The goal of this study was to estimate the persistence of restoration of squamous epithelium and the risk of cancer in BE that was eradicated using argon plasma coagulation (APC) in the absence of high-grade dysplasia, 16 years after its application.
DESIGN: We followed 32 patients with BE who underwent eradication of metaplastic epithelium using APC, up to 16 years later.
RESULTS: At the end of the initial treatment, 25 of 32 patients (78%) had complete endoscopic eradication, there was partial squamous re-epithelialization in four patients (13%) and it was absent in three patients (9%). We observed buried metaplastic glands under new squamous epithelium in 6 of the 25 patients who had complete endoscopic eradication. At follow-up, sustained complete endoscopic eradication was observed in 16 of 32 patients (50%), partial eradication in 11 of 32 patients (35%); there were two patients (6%) lost to follow-up and three patients (9%) developed esophageal adenocarcinoma. Two of the latest cases arose from the buried glands under neosquamous epithelium after complete eradication and one arose from a small remaining Barrett's segment.
CONCLUSIONS: We observed long-term re-epithelialization in the majority of patients who had previously had complete eradication of Barrett's esophagus. This did not provide protection against cancer development, as the incidence of cancers arising from buried glands or from residual Barrett's esophagus was similar to that observed in patients undergoing no specific treatment.

Entities:  

Keywords:  Argon plasma coagulation; Barrett’s esophagus; buried glands; endoscopic ablation; esophageal cancer; metaplastic epithelium

Year:  2014        PMID: 25360314      PMCID: PMC4212501          DOI: 10.1177/2050640614549095

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  29 in total

1.  Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.

Authors:  H Schulz; S Miehlke; D Antos; K U Schentke; M Vieth; M Stolte; E Bayerdörffer
Journal:  Gastrointest Endosc       Date:  2000-06       Impact factor: 9.427

Review 2.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

3.  Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.

Authors:  Jacobo Ortiz-Fernández-Sordo; Adolfo Parra-Blanco; Alejandro García-Varona; María Rodríguez-Peláez; Erika Madrigal-Hoyos; Irving Waxman; Luis Rodrigo
Journal:  World J Gastrointest Endosc       Date:  2011-09-16

4.  Submucosal injection of normal saline may prevent tissue damage from argon plasma coagulation: an experimental study using resected porcine esophagus, stomach, and colon.

Authors:  Mitsuhiro Fujishiro; Naohisa Yahagi; Masanori Nakamura; Naomi Kakushima; Shinya Kodashima; Satoshi Ono; Katsuya Kobayashi; Takuhei Hashimoto; Nobutake Yamamichi; Ayako Tateishi; Yasuhito Shimizu; Masashi Oka; Masao Ichinose; Masao Omata
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2006-10       Impact factor: 1.719

5.  Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).

Authors:  Hendrik Manner; Thomas Rabenstein; Oliver Pech; Kirsten Braun; Andrea May; Juergen Pohl; Angelika Behrens; Michael Vieth; Christian Ell
Journal:  Endoscopy       Date:  2013-12-18       Impact factor: 10.093

6.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

7.  Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus.

Authors:  Shinichi Ban; Mari Mino; Norman S Nishioka; William Puricelli; Lawrence R Zukerberg; Michio Shimizu; Gregory Y Lauwers
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

8.  Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.

Authors:  J L Van Laethem; M Cremer; M O Peny; M Delhaye; J Devière
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 9.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

10.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

View more
  1 in total

1.  ESGE Survey: worldwide practice patterns amongst gastroenterologists regarding the endoscopic management of Barrett's esophagus.

Authors:  Simon J Dunn; Laura J Neilson; Cesare Hassan; Prateek Sharma; Claire Guy; Colin J Rees
Journal:  Endosc Int Open       Date:  2016-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.